Manganese oxidation state mediates toxicity in PC12 cells.
The role of the manganese (Mn) oxidation state on cellular Mn uptake and toxicity is not well understood. Therefore, undifferentiated PC12 cells were exposed to 0-200 microM Mn(II)-chloride or Mn(III)-pyrophosphate for 24 h, after which cellular manganese levels were measured along with measures of cell viability, function, and cytotoxicity (trypan blue exclusion, medium lactate dehydrogenase (LDH), 8-isoprostanes, cellular ATP, dopamine, serotonin, H-ferritin, transferrin receptor (TfR), Mn-superoxide dismutase (MnSOD), and copper-zinc superoxide dismutase (CuZnSOD) protein levels). Exposures to Mn(III) >10 microM produced 2- to 5-fold higher cellular manganese levels than equimolar exposures to Mn(II). Cell viability and ATP levels both decreased at the highest Mn(II) and Mn(III) exposures (150-200 microM), while Mn(III) exposures produced increases in LDH activity at lower exposures (> or =50 microM) than did Mn(II) (200 microM only). Mn(II) reduced cellular dopamine levels more than Mn(III), especially at the highest exposures (50% reduced at 200 microM Mn(II)). In contrast, Mn(III) produced a >70% reduction in cellular serotonin at all exposures compared to Mn(II). Different cellular responses to Mn(II) exposures compared to Mn(III) were also observed for H-ferritin, TfR, and MnSOD protein levels. Notably, these differential effects of Mn(II) versus Mn(III) exposures on cellular toxicity could not simply be accounted for by the different cellular levels of manganese. These results suggest that the oxidation state of manganese exposures plays an important role in mediating manganese cytotoxicity.
Reaney
S H
SH
Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA. stevereaney@hotmail.com
Smith
D R
DR
D000255:Adenosine Triphosphate / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D002412:Cations / Q000737:chemistry; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002712:Chlorides; D011756:Diphosphates; D004298:Dopamine / Q000737:chemistry / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005293:Ferritins / Q000737:chemistry; D007424:Intracellular Fluid / Q000737:chemistry; D028421:Isoprostanes / Q000737:chemistry / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D017895:Manganese Compounds / Q000009:adverse effects* / Q000737:chemistry* / Q000378:metabolism; D016716:PC12 Cells; D051381:Rats; D011990:Receptors, Transferrin / Q000187:drug effects / Q000378:metabolism; D012701:Serotonin / Q000737:chemistry / Q000378:metabolism; D013482:Superoxide Dismutase / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism
D002412:Cations; D002712:Chlorides; D011756:Diphosphates; D028421:Isoprostanes; D017895:Manganese Compounds; D011990:Receptors, Transferrin; D012701:Serotonin; D000255:Adenosine Triphosphate; D005293:Ferritins; D007770:L-Lactate Dehydrogenase; D013482:Superoxide Dismutase; D004298:Dopamine